A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
Young Chul ParkYung Taek OuhMoon Hee SungHong Gyu ParkTae Jin KimChi Heum ChoJong Sup ParkJae Kwan LeePublished in: Journal of gynecologic oncology (2020)
ClinicalTrials.gov Identifier: NCT02195089.
Keyphrases